Mark Euwe
Posts by Mark Euwe:
Gilbert selected as Deep Tech Pioneer by Hello Tomorrow
We’re privileged to announce that we’ve been selected as one of the esteemed Hello Tomorrow Deep Tech Pioneers. Out of thousands of applications, our Smart Precision Inhaler solution stood out to their experts, and we couldn’t be more excited!
Dutch deep-tech investor DeepTechXL is truly excited that Gilbert, one of DeepTechXL’s disruptive technology portfolio companies, has been selected out of thousands of applicants by Hello Tomorrow. This reward underpins the novelty of Gilbert’s proprietary smart precision inhaler and emphasizes its potential to have a positive societal impact with improved drug delivery and therapy adherence for millions of patients.
Join us at the 10th Hello Tomorrow Global Summit in Paris on March 13-14, 2025, and connect with the world’s top innovators, industry leaders, investors, and deep tech visionaries.
Let’s shape the future of deep tech together to redefine treatment for lung patients!
Don’t miss out! 👉Global Summit – Hello Tomorrow
Gilbert joins DDL 2024 in Edinburgh
Gilbert looks forward to attending the annual DDL (Drug Delivery to the Lungs) conference in Edinburgh from Dec 11th-13th.
This year DDL is celebrating its 35th anniversary and this promises to be a landmark event attracting over 1000 scientists, academics, clinicians, regulators and industry experts worldwide, all with a focus on improving pulmonary drug delivery for serious lung diseases.
As we are working hard on the development of our Smart Precision Inhaler, we are especially looking forward to the session on Gene Therapy & Biologics for the Lungs and to explore how we can enable and improve the delivery of these important advances in treatment.
With mono-dispersed and customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for improved targeting and delivery of these innovative medicines.
Let’s redefine treatment for lung patients together!
So if you are also joining, let’s meet up in Edinburgh!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Scott Fleming, Mehmet Uzumcu or Maurits Huigen who will all be there.
Exploring the Future of Inhalation Drug Delivery
The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, in Parma, Italy from Sept 11th-13th.
As we are working hard on the development of our Smart Precision Inhaler, we look forward to connecting with professionals working on improvements in formulation and development of inhaled medicine.
With customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for the delivery of the innovative medicines under research today.
Let’s redefine treatment for lung patients together!
So if you are also visiting, let’s meet up in Parma!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Mehmet Uzumcu, Scott Fleming or Fatemeh Jahanmard who will be visiting the conference.
Gilbert joins ERS Congress in Vienna
The Gilbert team looks forward to attending the European Respiratory Society (ERS) in Vienna from Sept 7th-11th.
Our special interest is to catch up on the latest research in inhaled drug delivery therapies.
We look forward to connect with pharma and biotech decision makers to redefine treatment for lung patients together.
So if you are also visiting, let’s meet up in Vienna!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Maurits Huigen or Scott Fleming.
Gilbert is open for collaboration!
Gilbert is open for collaboration to redefine treatments for lung patients with an initial interest in improving inhaled anti-infective treatments.
Following our recent introduction at the SMI.London Conference on June 25th, we extend an invitation to Pharma, Biotech and Academia to collaborate and explore how electrospray can improve your inhaled therapy. The Gilbert team will work with you to optimize formulation and electrospray aerosol generation in our dedicated lab to ensure you reach your target.
Download our latest brochure ‘What’s your target?’ to learn more.
The brochure elaborates on the need for precision in pulmonary drug delivery, and the important role particle size and particle size distribution play. It presents how electrospray produces monodisperse droplets with customizable droplet size, enabling more precise targeting in the lungs. It also describes the unique Features & Benefits of the Gilbert Smart Precision Inhaler under development.
Interested to explore? Please contact us at info@gilbert.eu.
Let’s meet @ HLTH Europe Amsterdam
The Gilbert team will be visiting HLTH Europe 2024, coming 17-20 June in Amsterdam.
We look forward to connect with pharma and biotech decision makers to redefine treatment for lung patients together.
So if you are also visiting, let’s meet up in Amsterdam!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Maurits Huigen or Scott Fleming.
Just…. Gilbert !
We have changed our company brand from Gilbert Technologies to just ….. Gilbert!
This change reflects an underlying change in our legal structure, where Gilbert Innovation, Gilbert Therapeutics and Gilbert Technologies are now all subsidiaries of the Gilbert Group.
Our mission remains the same: Redefining treatment for lung patients
Please note that we changed our domain name to: Gilbert.eu
For any questions, please contact us at info@Gilbert.eu and/or follow us on Linkedin.